Alzheimer’s Drug Discovery Foundation (ADDF): LOI
| Name: |
Alzheimer’s Drug Discovery Foundation (ADDF): LOI Application deadline: 15/11/16 |
|---|---|
| General description: |
Supports clinical trials of novel or repurposed drugs for FTD and related disorders (bvFTD, PPA, PSP, CBD, FTD/ALS) through a partnership with The Association for Frontotemporal Degeneration. Funding: $500,000-$2,000,000 for 1-3 years. http://www.alzdiscovery.org/research-and-grants/funding-opportunities
|
| Source: | Foreign |
| Budget: | $500,000-$2,000,000 |
| Number of research years: | 1-3 |
| Contact person: | Robi, 2152, robertg@trdf.technion.ac.il; Michal, 1745, michall@trdf.technion.ac.il |
| Fields: | Life Sciences and medicine |
| Type of fund: | The fund is not a competitive fund |
| Related fund and profiles: | Alzheimer’s Drug Discovery Foundation - ADDF ,Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner) |